You are here: Industry Insights > Terumo

News List

Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare prnasia
September 23, 2021
Terumo Corporation (TSE: 4543), a global leader in medical technology, today celebrates its 100th anniversary. The company, based in Tokyo, boasts over 25,000 associates worldwide...
Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy prnasia
August 12, 2021
Terumo and PhotonPharma today announced they have established a memorandum of understanding (MOU) for collaboration to develop Innocell™, a novel tumor specific immunotherapy (a therapeutic vaccine) for solid tumors.
Terumo and UMCU strengthen their partnership to develop solutions in Interventional Oncology prnasia
July 21, 2021
Terumo Europe and University Medical Center Utrecht (UMC Utrecht) announced that they signed a Memorandum of Understanding (MoU) to recognize the longstanding partnership in the field of oncology.
A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device Completes Clinical Study in Japan prnasia
February 08, 2021
Terumo Corporation today announced the completion of a clinical study in Japan for a product using Terumo's automated injection device developed in collaboration with Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin).
Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field prnasia
July 16, 2020
Terumo Corporation (TSE: 4543) today announced it has completed the acquisition of Quirem Medical B.V., a Netherlands-based healthcare startup specializing in the development of next-generation microspheres for Selective Internal Radiation Therapy (SIRT),